页数:65页文件大小:6.15 MB来源: 生物化学ppt课件
本课件为英文教材的后续章节,主题是酶的专一性与活性调控:先讲专一性源于分子识别,通过诱导契合与过渡态稳定实现,并以己糖激酶为例说明构象变化;随后讲酶活性的调控策略,包括蛋白酶水解激活、同工酶、可逆共价修饰与调节蛋白的作用,并以消化蛋白酶、胰岛素、血液凝固与乳酸脱氢酶为例。
9.1•Specificity Is the Result of Molecular Recognition “Induced Fit” and the Transition-State Intermediate
Key and lockInduce fit
The induced conformational change in hexokinaseM11.8Induced fit is the main model for changes in the enzyme to fit the transition state and to bring functional side groups of the enzyme to the right location to help the catalysis.
8.2 •Controls Over Enzymatic Activity—General Considerations
Specialized controls: Enzyme regulation is an important matter to cells, and evolution has provided a variety of additional options, including zymogens, isozymes, and modulator proteins
zymogensMost proteins become fully active as their synthesis is completed and they spontaneously fold into their native, three-dimensional conformations. Some proteins, however, are synthesized as inactive precursors, called zymogensor proenzymes,that only acquire full activity upon specific proteolytic cleavage of one or several of their peptide bonds.
Insulin. Some protein hormones are synthesized in the form of inactive precursor molecules, from which the active hormone is derived by proteolysis. For instance, insulin,an important metabolic regulator, is generated by proteolytic excision of a specific peptide from proinsulin
IsozymesLDH (lactate dehydrogenase) isozymesdiffer in theirallosteric regulation by pyruvate.
The kinetic properties of the various LDH isozymes differ in terms of their relative affinities for the various substrates and their sensitivity to inhibition by product. Different tissues express different isozyme forms, as appropriate to their particular metabolic needs. By regulating the relative amounts of A and B subunits they synthesize, the cells of various tissues control which isozymic forms are likely to assemble, and, thus, which kinetic parameters prevail.
Blood clottingFibrin fiber
Conversion of fibrinogen to fibrin causes clotting.The final step of clotting is conversion of fibrinogen to fibrin by thrombin, a protease.Fibrinogen has 6 protein chains (2x A, Band ), folded into globular units connected by rods. Thrombin cleaves 4 peptides from the Aand Bchains in the central globule, resulting in fibrin monomer ()2.
Carboxyl ends of the -and chains interact with the newly exposed N-terminal regions => polymerization (protofibrils).
Fibrils are stabilized by cross-linking: formation of amide bonds between lysine and glutamine by transglutaminase, which is activated from protransglutaminase by thrombin.The network of fibrils forms the clot.
Activation of thrombin.Thrombin activates fibrinogen, but how is thrombin activated ?Thrombin is activated by proteolytic activation of prothrombin with factors Xa(also a protease) and Va. Activation removes a glaand 2 kringledomains.Modular structure of prothrombin
Modulator Proteins Modulator proteinsare proteins that bind to enzymes, and by binding, influence the activity of the enzyme.Cyclic AMp-dependent protein kinase is a 150-to 170-kD R2C2tetramer in mammalian cells. The two R (regulatory) subunits bind cAMP (KD= 3 x 10-8M); cAMP binding releases the R subunits from the C (catalytic) subunits. C subunits are enzymatically active as monomersactiveinactive
Covalent modification(Reversible) covalent modification alters properties of proteins (for example: enzyme activity).
Many enzymes/proteins involved in signal transduction and membrane channels are regulated by phos
下载地址:{{downurl}}
{{{a}}}
{{#b}}{{{b}}}
{{/b}} {{/title}} {{#nolog}}登陆注册
{{/nolog}} {{#djsx}}点我刷新
{{/djsx}} {{#gocz}} {{/gocz}} {{#ffqr}} {{/ffqr}}